Influence of bacterial resistance on mortality in intensive care units: a registry study from 2000 to 2013 (IICU Study).


Journal

The Journal of hospital infection
ISSN: 1532-2939
Titre abrégé: J Hosp Infect
Pays: England
ID NLM: 8007166

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 07 11 2018
accepted: 09 01 2019
pubmed: 20 1 2019
medline: 30 11 2019
entrez: 20 1 2019
Statut: ppublish

Résumé

Bacterial resistance to antibiotics is a daily concern in intensive care units. However, few data are available concerning the clinical consequences of in-vitro-defined resistance. To compare the mortality of patients with nosocomial infections according to bacterial resistance profiles. The prospective surveillance registry in 29 French intensive care units (ICUs) participating during the years 2000-2013 was retrospectively analysed. All patients presenting with a nosocomial infection in ICU were included. The registry contained 88,000 eligible patients, including 10,001 patients with a nosocomial infection. Among them, 3092 (36.7%) were related to resistant micro-organisms. Gram-negative bacilli exhibited the highest rate of resistance compared to Gram-positive cocci (52.8% vs 48.1%; P < 0.001). In-hospital mortality was higher in cases of patients with antibiotic-resistant infectious agents (51.9% vs 45.5%; P < 0.001), and critical care length of stay was longer (33 ± 26 vs 29 ± 22 days; P < 0.001). These results remained significant after SAPS II matching (P < 0.001) and in the Gram-negative bacilli and Gram-positive cocci subgroups. No difference in mortality was found with respect to origin prior to admission. Patients with bacterial resistance had higher ICU mortality and increased length of stay, regardless of the bacterial species or origin of the patient.

Sections du résumé

BACKGROUND BACKGROUND
Bacterial resistance to antibiotics is a daily concern in intensive care units. However, few data are available concerning the clinical consequences of in-vitro-defined resistance.
AIM OBJECTIVE
To compare the mortality of patients with nosocomial infections according to bacterial resistance profiles.
METHODS METHODS
The prospective surveillance registry in 29 French intensive care units (ICUs) participating during the years 2000-2013 was retrospectively analysed. All patients presenting with a nosocomial infection in ICU were included.
FINDINGS RESULTS
The registry contained 88,000 eligible patients, including 10,001 patients with a nosocomial infection. Among them, 3092 (36.7%) were related to resistant micro-organisms. Gram-negative bacilli exhibited the highest rate of resistance compared to Gram-positive cocci (52.8% vs 48.1%; P < 0.001). In-hospital mortality was higher in cases of patients with antibiotic-resistant infectious agents (51.9% vs 45.5%; P < 0.001), and critical care length of stay was longer (33 ± 26 vs 29 ± 22 days; P < 0.001). These results remained significant after SAPS II matching (P < 0.001) and in the Gram-negative bacilli and Gram-positive cocci subgroups. No difference in mortality was found with respect to origin prior to admission.
CONCLUSION CONCLUSIONS
Patients with bacterial resistance had higher ICU mortality and increased length of stay, regardless of the bacterial species or origin of the patient.

Identifiants

pubmed: 30659869
pii: S0195-6701(19)30013-1
doi: 10.1016/j.jhin.2019.01.011
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

317-324

Informations de copyright

Copyright © 2019 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Auteurs

V Bonnet (V)

Department of Anaesthesiology and Critical Care, University Hospital of Caen, Caen, France.

H Dupont (H)

Anaesthesiology and Critical Care Department, Amiens University Medical Center, Amiens, France; INSERM U 1088, University of Picardie Jules Verne, Centre Universitaire de Recherche en Santé, Amiens, France.

S Glorion (S)

Regional Coordinating Centre for Healthcare-Associated Infections Control (CClin Ouest), Rennes, France.

M Aupée (M)

Regional Coordinating Centre for Healthcare-Associated Infections Control (CClin Ouest), Rennes, France.

E Kipnis (E)

Department of Anaesthesiology and Critical Care - CHU Lille, Lille, France; Host-Pathogen Translational Research, EA 7366, University of Lille, Lille, France.

J L Gérard (JL)

Department of Anaesthesiology and Critical Care, University Hospital of Caen, Caen, France; Normandie Université, Esplanade de la Paix, CS 14 032, Caen, France.

J L Hanouz (JL)

Department of Anaesthesiology and Critical Care, University Hospital of Caen, Caen, France; Normandie Université, Esplanade de la Paix, CS 14 032, Caen, France.

M O Fischer (MO)

Department of Anaesthesiology and Critical Care, University Hospital of Caen, Caen, France; Normandie Université, Esplanade de la Paix, CS 14 032, Caen, France. Electronic address: fischer-mo@chu-caen.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH